![Logo for Omega Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F810ba-2024-05-28-08-11-57.png&w=256&q=100)
Omega Therapeutics Inc Investor Relations Material
Latest events
![Logo for Omega Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F810ba-2024-05-28-08-11-57.png&w=128&q=100)
Study Update
Omega Therapeutics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Omega Therapeutics Inc
Access all reports
Omega Therapeutics Inc. is a clinical-stage biotechnology company focused on developing a new class of programmable epigenomic mRNA medicines. The company's OMEGA platform enables precise control of gene expression without altering native nucleic acid sequences, aiming to address the root causes of various diseases. Omega's therapeutic candidates target a range of conditions, including oncology, regenerative medicine, and multigenic and monogenic diseases. Founded in 2017 by Flagship Pioneering, Omega Therapeutics is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Omega Therapeutics Inc
![2
1.00
Site - sp](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fomega-therapeutics-inc-study-update-6665d1e553679a11%2F10.png&w=3840&q=75)
![Logo for Omega Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F810ba-2024-05-28-08-11-57.png&w=128&q=100)
Study Update
Omega Therapeutics Inc
![Pioneering A New Era](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fomega-therapeutics-inc-study-update-6665d1e553679a11%2F5.png&w=3840&q=75)
![Logo for Omega Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F810ba-2024-05-28-08-11-57.png&w=128&q=100)
Study Update
Omega Therapeutics Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
OMGA
Country
🇺🇸 United States